Olle Sangfelt

5PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 11, 2022
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.

Anna Borgenvik, Karl O Holmberg, Sara Bolin

|Mar 04, 2021
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma.

Belamy B Cheung, Ane Kleynhans, Rituparna Mittra

|Jul 07, 2020
PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer.

Andrä Brunner, Aldwin Suryo Rahmanto, Henrik Johansson

|Feb 16, 2017
Targeting SOX9 for degradation to inhibit chemoresistance, metastatic spread, and recurrence.

Aldwin Suryo Rahmanto, Fredrik J Swartling, Olle Sangfelt

|Sep 15, 2016
FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma.

Aldwin Suryo Rahmanto, Vasil Savov, Andrä Brunner

Pageof 1